Outset Medical to Present at SVB Leerink Global Healthcare Conference
04 Février 2022 - 2:00PM
Business Wire
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical
technology company pioneering a first-of-its-kind technology to
reduce the cost and complexity of dialysis, today announced that
members of management will participate in a fireside chat at the
SVB Leerink 11th Annual Global Healthcare Conference on Friday,
February 18, 2022 at 12:40pm PT / 3:40pm ET.
A live and archived webcast of the fireside chat will be
available on the “Investors” section of the Outset website at
https://investors.outsetmedical.com/.
About Outset Medical, Inc.
Outset is a medical technology company pioneering a
first-of-its-kind technology to reduce the cost and complexity of
dialysis. The Tablo Hemodialysis System, FDA cleared for use from
the hospital to the home, represents a significant technological
advancement that transforms the dialysis experience for patients
and operationally simplifies it for providers. Tablo serves as a
single enterprise solution that can be utilized across the
continuum of care, allowing dialysis to be delivered anytime,
anywhere and by anyone. The integration of water purification and
on-demand dialysate production enables Tablo to serve as a dialysis
clinic on wheels, with 2-way wireless data transmission and a
proprietary data analytics platform powering a new holistic
approach to dialysis care. Tablo is a registered trademark of
Outset Medical, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220204005032/en/
Jim Mazzola Vice President, Investor Relations
jmazzola@outsetmedical.com
Brian Johnston Gilmartin Group investors@outsetmedical.com
Grupo Aeroportuario del ... (NASDAQ:OMAB)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Grupo Aeroportuario del ... (NASDAQ:OMAB)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025
